Image via Endpoints News
Last updated
Biogen: Product Launch
Biogen's monoclonal antibody felzartamab received first global approval in China for second-line multiple myeloma treatment, in combination with lenalidomide and dexamethasone.
Source: Endpoints News
The leadership read
Biogen's launch shifts talent demand before revenue catches up. In Biotech & Pharma, taking a release to scale rewards product leaders with a commercial edge and operators who build the post-launch motion. Watch whether Biogen backs it with senior go-to-market hires across Asia — that separates a platform move from a one-off.
Market context: The wider read — a Talent Market Index of 100.4 (Neutral), down 1.1 month-on-month — shows Asia signal flow steady (-1.3pts).
Biogen: 7 signals in the last 90 days — above the Biotech & Pharma median of 1 across 25 tracked companies; 0.2% of MitchelLake's Americas signal flow; 8 tracked across 92 days.
MitchelLake in this thematic
Also at Biogen →
More signals across Biotech & Pharma
Product Launch · Asia
Celltrion →Celltrion achieved record quarterly earnings (1.4 trillion won / $950M in sales, 451.8B won operating profit) driven by growing sales of newer biosimilar portfolio and improved manufacturing efficiency. YoY sales growth of 45% and operating profit growth of 86.3%.
Product Launch · Asia
Bristol Myers Squibb →Bristol Myers Squibb launched Relopduo, a fixed-dose combination dermatology-cancer drug, in India. The drug received USFDA approval in 2022 and is now being commercialized in the Indian market.
Partnership · Asia
Bora Pharmaceuticals →Bora Pharmaceuticals signed partnership with Insilico Medicine for AI drug discovery. Company launched group-wide AI in Manufacturing program (BORA AIM) to improve process efficiency across sites.
Ma Activity · Asia
Torrent Pharmaceuticals →NCLT (National Company Law Tribunal) approved Torrent Pharma acquisition of JB Chemicals; merger scheme to take effect after Registrar of Companies filing
Restructuring · Asia
Samsung Biologics →Samsung Biologics unionized workers voted to leave the Samsung Group United Union and form an independent labor union, following months of work-to-rule campaigns and strikes over pay and working conditions.
Geographic Expansion · Asia
Thermo Fisher Scientific →Thermo Fisher Scientific's Manila Shared Services Centre is scaling rapidly from 100 to ~700 employees by 2026, positioning itself as a high-impact regional hub for Asia-Pacific operations with focus on digital transformation and strategic value creation beyond cost efficiency.
Where this lands in our work
- Enterprise Innovation & Transformation →
A launch is the output of a product and engineering leadership layer built before it.
- Executive Search — Asia →
Our Asia practice runs the searches behind signals like this one.
Intelligence powered by Autonodal ↗
Nearby in the record